Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?

IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Anton Tomšič MD, PhD , Maria Chiara Meucci MD , Anne R. de Jong MD , Jerry Braun MD, PhD , Nina Ajmone Marsan MD, PhD , Robert J.M. Klautz MD, PhD , Meindert Palmen MD, PhD
{"title":"Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?","authors":"Anton Tomšič MD, PhD ,&nbsp;Maria Chiara Meucci MD ,&nbsp;Anne R. de Jong MD ,&nbsp;Jerry Braun MD, PhD ,&nbsp;Nina Ajmone Marsan MD, PhD ,&nbsp;Robert J.M. Klautz MD, PhD ,&nbsp;Meindert Palmen MD, PhD","doi":"10.1016/j.jjcc.2023.12.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Clinical and echocardiographic results of valve repair for mitral regurgitation in the setting of atrial fibrillation are poorly studied.</p></div><div><h3>Methods</h3><p>Between January 2008 and December 2020, 89 patients underwent valve repair for mitral regurgitation in the setting of atrial fibrillation. Clinical and echocardiographic follow-up data were collected and studied. The primary composite endpoint consisted of all-cause mortality or hospitalization for heart failure.</p></div><div><h3>Results</h3><p>Valve repair with true-sized annuloplasty was performed in 83 (93 %) and restrictive annuloplasty in 6 (7 %) patients. Early mortality occurred in 3 (3 %) and residual mitral regurgitation in 1 (1 %) patient. During a median follow-up of 5.4 years (interquartile range 3.4–9.5), 25 patients died, 6 due to end-stage heart failure. Ten patients were hospitalized for heart failure. The estimated event-free survival rate at 10 years was 48.2 % (95 % CI 33.5 %–62.9 %). Recurrent mitral regurgitation was observed in 14 patients and most often caused by leaflet tethering. When analyzed as a time-dependent variable, recurrent regurgitation was related to the occurrence of the primary endpoint (hazard ratio 3.192, 95 % CI 1.219–8.359, <em>p</em> = 0.018). On exploratory sub-analyses, no recurrent regurgitation was observed after restrictive annuloplasty or in patients with paroxysmal atrial fibrillation. Moreover, recurrent regurgitation was observed more often when signs of left ventricular impairment were present preoperatively.</p></div><div><h3>Conclusions</h3><p>Despite good initial results, recurrent regurgitation was a frequent observation after valve repair for mitral regurgitation in atrial fibrillation and had an effect on heart failure related morbidity and mortality. Refinements in the timing of surgery and surgical technique might help improve outcomes.</p></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0914508723002952/pdfft?md5=5cbbb673adb35b7c1eeefcd54a2634f6&pid=1-s2.0-S0914508723002952-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0914508723002952","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Clinical and echocardiographic results of valve repair for mitral regurgitation in the setting of atrial fibrillation are poorly studied.

Methods

Between January 2008 and December 2020, 89 patients underwent valve repair for mitral regurgitation in the setting of atrial fibrillation. Clinical and echocardiographic follow-up data were collected and studied. The primary composite endpoint consisted of all-cause mortality or hospitalization for heart failure.

Results

Valve repair with true-sized annuloplasty was performed in 83 (93 %) and restrictive annuloplasty in 6 (7 %) patients. Early mortality occurred in 3 (3 %) and residual mitral regurgitation in 1 (1 %) patient. During a median follow-up of 5.4 years (interquartile range 3.4–9.5), 25 patients died, 6 due to end-stage heart failure. Ten patients were hospitalized for heart failure. The estimated event-free survival rate at 10 years was 48.2 % (95 % CI 33.5 %–62.9 %). Recurrent mitral regurgitation was observed in 14 patients and most often caused by leaflet tethering. When analyzed as a time-dependent variable, recurrent regurgitation was related to the occurrence of the primary endpoint (hazard ratio 3.192, 95 % CI 1.219–8.359, p = 0.018). On exploratory sub-analyses, no recurrent regurgitation was observed after restrictive annuloplasty or in patients with paroxysmal atrial fibrillation. Moreover, recurrent regurgitation was observed more often when signs of left ventricular impairment were present preoperatively.

Conclusions

Despite good initial results, recurrent regurgitation was a frequent observation after valve repair for mitral regurgitation in atrial fibrillation and had an effect on heart failure related morbidity and mortality. Refinements in the timing of surgery and surgical technique might help improve outcomes.

Abstract Image

Abstract Image

心房颤动中的二尖瓣反流:简单的修复足以解决复杂的问题吗?
背景心房颤动患者二尖瓣返流瓣膜修复的临床和超声心动图结果研究甚少。方法:2008年1月至2020年12月,89例心房颤动患者因二尖瓣返流接受瓣膜修复。收集和研究临床和超声心动图随访资料。主要综合终点包括全因死亡率或心力衰竭住院。结果83例(93 %)患者行真大小环成形术,6例(7 %)患者行限制性环成形术。早期死亡3例(3 %),残留二尖瓣返流1例(1 %)。在中位随访5.4 年(四分位数范围3.4-9.5)期间,25例患者死亡,6例死于终末期心力衰竭。10名患者因心力衰竭住院。估计10 年无事件生存率为48.2% %(95 % CI 33.5 % -62.9 %)。复发性二尖瓣返流14例,多由小叶栓系引起。当作为一个时间相关变量进行分析时,复发性反流与主要终点的发生有关(风险比3.192,95 % CI 1.219-8.359, p = 0.018)。在探索性亚分析中,限制性环成形术后或阵发性心房颤动患者未观察到复发性反流。此外,当术前出现左心室损伤的迹象时,返流更常被观察到。结论:尽管初步效果良好,但心房颤动二尖瓣返流瓣膜修复后复发性返流是常见的观察结果,并对心力衰竭相关的发病率和死亡率有影响。手术时机和手术技术的改进可能有助于改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信